HIGH YIELD Flashcards

1
Q

a major cause of atherosclerotic
cardiovascular disease

(ASCVD) e.g. coronary artery
disease, ischemic cerebrovascular disease, and peripheral vascular disease

A

Dyslipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

the leading cause of death for both genders in the U.S.

A

Atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Total cholesterol and LDL-C increase throughout life

in men and women, T/F?

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cholesterol and triglycerides are transported in the _____ via _____?

A

plasma

lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Responsible for structure, function, assembly, metabolism

A

Apolipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what percent of IDL gets removed from the liver?

A

40-60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • HDL (high density)
  • LDL (low density)
  • IDL (intermediate density)
  • VLDL (very low density)
  • Chylomicrons

these are examples?

A

Lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

general presentation? symptoms?

so what would cause these?

A

often asymptomatic until event; variable, often none

coronary heart disease
PAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how do the labs present?

A
  • Elevated total cholesterol
  • Elevated LDL
  • Elevated triglycerides
  • Elevated ApoB
  • Elevated hsCRP • Low HDL
  • Screen for PAD (ABI), diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
• HeFH is more common
with one case per 250
people versus HoFH with
one case per one million
people

• HeFH ~250-450; HoFH
may present with TG >500

• Eruptive xanthomas
and/or pancreatitis can
develop when TG > 500
mg/dL

A

Familial Hypercholesterolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Group of conditions that
associated with increased
risk of heart disease,
stroke, and diabetes

Requires aggressive
lifestyle modification
focused on weight
reduction and increased
physical activity
Reduction of risk factors for
CVD include treatment of
• HTN
• Smoking
• Glucose
• Weight
• Cholesterol
A

Metabolic Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment Approach

A
  • Reduce the risk of first and recurrent ASCVD events
  • Implement a healthy lifestyle!

• Initiation of medication should be based on risk
and not merely plasma levels (e.g. LDL)

• Risk assessment is key (10-year ASCVD risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

10-year risk for ASCVD is categorized as:

low risk
borderline risk
intermediate risk
high risk

A

Low-risk (<5%)

Borderline risk (5% to 7.4%)

Intermediate risk (7.5% to 19.9%)

High risk (≥20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Secondary Prevention

*treated with?

A

Clinical diagnosis of atherosclerotic cardiovascular
disease (ASCVD) includes:

• Acute coronary syndrome
• Myocardial infarction
• Stable or unstable angina or arterial
revascularization
• Stroke and transient ischemic attack
• Peripheral artery disease, including aortic
aneurysm

statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of Very High TG

A
  • > 500 mg/dL, treat with statins(10-30) and fibrates(30-50)
  • Primary goal is to prevent pancreatitis***
  • Weight loss of 5%-10% à 20% reduction in TG
  • Limit sugars and other simple carbs and increase aerobic exercise
  • Evaluate secondary causes
  • Diet
  • Medications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Low HDL Cholesterol

A
  • Strong independent risk predictor of ASCVD
  • Men < 40 mg/dL***
  • Women < 50 mg/dL***
  • Niacin can increase HDL significantly (~30—40%)***
  • However, lifestyle modification is the key recommendation
17
Q

Aspirin (can be considered for primary prevention if

ASCVD risk is high and NOT at increased bleeding risk, T/F?

A

T

18
Q

pharmacologic treatment?

A
  • Inhibitors of HMG-CoA reductase (statins)
  • Bile acid–binding resins
  • Nicotinic acid (niacin)
  • Omega-3 fatty acids
19
Q

250-450

HeFH ~or HoFH

A

HeFH

20
Q

HoFH may present with TG >500

HeFH ~or HoFH

A

HoFH

21
Q

what are the parameters for metabolic syndrome?

A
glucose
HDL cholesterol
triglycerides
obesity
hypertension